Skip to main content

Table 2 Adjusted linear mixed model of liver stiffness (measured in kPa, n = 676 )

From: Liver stiffness and associated risk factors among people with a history of injecting drugs: a prospective cohort study

Fixed effects

Effect estimate baseline

Time trend (per year)

Estimate (95% CI)

Estimate (95% CI)

Yearly LSM change

-

2.81 (0.56; 5.0)*

Age per 10 years increase

1.0 (0.68; 1.3)*

-0.18 (-0.45; 0.088)

Regular alcohol usea

1.3 (0.46; 2.0)*

-0.046 (-0.67; 0.58)

High substance useb

0.66 (-0.96; 2.3)

-0.48 (-1.9; 0.94)

Body mass index (kg/m2)

0.25 (0.17; 0.32)*

-0.079 (-0.14; -0.013)*

Hepatitis C RNA positivec

1.2 (0.54; 1.9)*

-

Low HDL Cholesterold

1.4 (0.64; 2.2)*

-0.55 (-1.2; 0.08)

Elevated HbA1ce

3.1 (0.68; 5.5)*

4.6 (2.3; 6.9)*

Hepatitis C status changef

-

-0.73 (-1.3; -0.21)*

  1. The constant term (β0) was -5.4 (CI -8.0; -2.8). Except for HCV status, the time trend indicates the effect of the variable remaining at baseline levels over time. 274 participants had two or more liver stiffness measurements. Significantly associated (p < 0.05) variables are labelled with bold text and an asterisk
  2. aUsing alcohol on one or more days per week during the past 12 months
  3. bThe iSUSI is a continuous variable ranging from 0–1, were (1) indicates the effect of maximum substance use and (0) indicates the effect of no substance use
  4. cHepatitis C virus RNA positive at baseline
  5. dBelow 1.3 mmol/L for women and 1.0 mmol/L for men
  6. eAbove 48 mmol/mol, indicating type 2 diabetes
  7. fResolved hepatitis C infection compared with no change in HCV infection status from baseline to the following liver stiffness measurements
Back to article page

Substance Abuse Treatment, Prevention, and Policy

ISSN: 1747-597X